1 | odds | 17,857 |
2 | apob/apoa-i | 33 |
3 | 30:15 | 24 |
4 | alc/amc | 23 |
5 | trough-to-peak | 16 |
6 | cost-to-charge | 11 |
7 | mtdna/gdna | 10 |
8 | neutrophil-lymphocyte | 10 |
9 | ang-1/ang-2 | 9 |
10 | campesterol-to-lathosterol | 9 |
11 | feed-to-gain | 8 |
12 | heterophil/lymphocyte | 8 |
13 | lacman | 8 |
14 | liver-to-spleen | 8 |
15 | sdfv | 8 |
16 | vat/sat | 8 |
17 | arginine-to-dimethylarginine | 7 |
18 | cerebral-umbilical | 7 |
19 | crystalloid/colloid | 7 |
20 | csf/serum | 7 |
21 | hmax/mmax | 7 |
22 | nicotine/cotinine | 7 |
23 | sflt1/plgf | 7 |
24 | ecp/eo | 6 |
25 | gmeans | 6 |
26 | iodine-to-creatinine | 6 |
27 | myosin/actin | 6 |
28 | peto-odds | 6 |
29 | sam/sah | 6 |
30 | testosterone/estradiol | 6 |
31 | val/lys | 6 |
32 | adiponectin-leptin | 5 |
33 | apoj/pon | 5 |
34 | cholesterol/triglyceride | 5 |
35 | g/r | 5 |
36 | pce/nce | 5 |
37 | st/s | 5 |
38 | stj/aa | 5 |
39 | vat/tat | 5 |
40 | 'odds | 4 |
41 | 2:16 | 4 |
42 | area-to-mass | 4 |
43 | asleep/awake | 4 |
44 | bacillus/coccus | 4 |
45 | cholestanol-to-cholesterol | 4 |
46 | col2/20 | 4 |
47 | hamstrings-to-quadriceps | 4 |
48 | icsv/dicsv | 4 |
49 | ldl/ldl-c | 4 |
50 | total-c/hdl-c | 4 |
51 | uv/ma | 4 |
52 | 5-hiaa/5-ht | 3 |
53 | apo-b/apo-ai | 3 |
54 | apoa-1/apob | 3 |
55 | asp/bsp | 3 |
56 | c16/c18 | 3 |
57 | campesterol-to-cholesterol | 3 |
58 | capillary-to-fiber | 3 |
59 | carbohydrate-to-insulin | 3 |
60 | carbohydrate-to-protein | 3 |
61 | chol/hdl | 3 |
62 | cortisol/dhea-s | 3 |
63 | cost-charge | 3 |
64 | desmosterol/cholesterol | 3 |
65 | ecp/albumin | 3 |
66 | enterobacteriaceae/bacteroidaceae | 3 |
67 | firmicutes/bacteroidetes | 3 |
68 | ifn-γ/il-10 | 3 |
69 | il-6-to-il-10 | 3 |
70 | inhabitation | 3 |
71 | insulin-to-carbohydrate | 3 |
72 | nucleus-to-cytoplasm | 3 |
73 | pa/oa | 3 |
74 | pai-1/pai-2 | 3 |
75 | picp/ictp | 3 |
76 | population-to-neurosurgeon | 3 |
77 | precursor-to-product | 3 |
78 | preventer-to-reliever | 3 |
79 | qtc/qtt | 3 |
80 | rc/abd | 3 |
81 | subscapular/triceps | 3 |
82 | tg/cholesterol | 3 |
83 | valid-invalid | 3 |
84 | 'hdl-cholesterol | 2 |
85 | +dp/dtmax-edv | 2 |
86 | 20:3/18:2 | 2 |
87 | abstract-to-publication | 2 |
88 | activator/adhesive | 2 |
89 | aldosterone-renin | 2 |
90 | aldosterone/bnp | 2 |
91 | ang-2/ang-1 | 2 |
92 | apo-b/apo-a1 | 2 |
93 | apob100/apoa1 | 2 |
94 | benefit/harms | 2 |
95 | c-peptide/creatinine | 2 |
96 | carbohydrate/protein-equivalent | 2 |
97 | ceramide/cholesterol | 2 |
98 | chlorophyll/carotenoid | 2 |
99 | cholesterol-phospholipids | 2 |
100 | cholesterol/lecithin | 2 |
101 | choline-to-creatine | 2 |
102 | drisk | 2 |
103 | drug/beeswax | 2 |
104 | edv/mass | 2 |
105 | enzyme-to-substrate | 2 |
106 | evol/avol | 2 |
107 | gsh-to-gssg | 2 |
108 | heart-mediastinum | 2 |
109 | heart-to-lung | 2 |
110 | heterophil-to-lymphocyte | 2 |
111 | hop-1 | 2 |
112 | hva/da | 2 |
113 | icpmax-to-map | 2 |
114 | igg2a/igg1 | 2 |
115 | ihad/ihab | 2 |
116 | il-18/il-10 | 2 |
117 | il-4/interferon-gamma | 2 |
118 | insulin-to-glucagon | 2 |
119 | l-arginine/adma | 2 |
120 | losartan/e-3174 | 2 |
121 | lung/myocardium | 2 |
122 | mda/sod | 2 |
123 | media-to-lumen | 2 |
124 | mg-to-a1c | 2 |
125 | mpv-to-spleen | 2 |
126 | muscle-thickness | 2 |
127 | n2ba/n2b | 2 |
128 | naa-to-choline | 2 |
129 | naa-to-creatine | 2 |
130 | neopterin-to-creatinine | 2 |
131 | nucleus/cytoplasm | 2 |
132 | pem/pwt | 2 |
133 | protamine-to-heparin | 2 |
134 | r-tfa/sfa | 2 |
135 | r/o | 2 |
136 | rantes/il-8 | 2 |
137 | redfield | 2 |
138 | root/shoot | 2 |
139 | sphingomyelin/lecithin | 2 |
140 | sun/creatinine | 2 |
141 | surface-area-to-mass | 2 |
142 | surfactant/oil | 2 |
143 | swt/twt | 2 |
144 | tag/hdl-c | 2 |
145 | timp-1/mmp-3 | 2 |
146 | torsion-to-shortening | 2 |
147 | waist-thigh | 2 |
148 | δdhpg/δne | 2 |
149 | 'hazard | 1 |
150 | 'p/n | 1 |
151 | 'wall-to-lumen | 1 |
152 | 'win | 1 |
153 | +p/p | 1 |
154 | 1-ohp/3-ohbap | 1 |
155 | 17hsd1/17hsd2 | 1 |
156 | 18:2/18:1 | 1 |
157 | 2/16α-oh | 1 |
158 | 20:4n-6/20:5n-3 | 1 |
159 | 2:16α-hydroxyestrone | 1 |
160 | 30∶15 | 1 |
161 | 4-/6-sulfated | 1 |
162 | 4:2:1 | 1 |
163 | 4r/3r | 1 |
164 | 5-methylfurfural/2-acetylfuran | 1 |
165 | 5α/5β-the | 1 |
166 | 6-h/0-h | 1 |
167 | 8:1:9 | 1 |
168 | 8:2:2 | 1 |
169 | 9:7:7 | 1 |
170 | a260-280 | 1 |
171 | a260/280 | 1 |
172 | above-the-knee/elbow-the-knee | 1 |
173 | acth/e | 1 |
174 | adiponectin/fabp4 | 1 |
175 | ag-to-uag | 1 |
176 | ag/tg | 1 |
177 | albuminuria-to-creatinine | 1 |
178 | aldosterone-to-creatinine | 1 |
179 | am/em | 1 |
180 | amylose/amylopectin | 1 |
181 | anaerobe-to-aerobe | 1 |
182 | analyte/creatinine | 1 |
183 | anti-xa/iia | 1 |
184 | apo-b/apo-a-1 | 1 |
185 | apo-b100/apo-a1 | 1 |
186 | apoa-i/apoc-iii | 1 |
187 | apob-100/b-48 | 1 |
188 | apoc-iii/apoc-ii | 1 |
189 | b/se | 1 |
190 | background-to-signal | 1 |
191 | bacteroidetes-to-firmicutes | 1 |
192 | balloon/annulus | 1 |
193 | bax/bcl-2expression | 1 |
194 | bax\bcl-2 | 1 |
195 | benefits-risk | 1 |
196 | beta/alpha-lipoprotein | 1 |
197 | blackburne-peel | 1 |
198 | body-surface-to-mass | 1 |
199 | brm/mp | 1 |
200 | bromide/chlorine | 1 |
201 | c-ldl/c-hdl | 1 |
202 | c16:1n-7/c16:0 | 1 |
203 | c18:2/c18:3 | 1 |
204 | c20:5n-3/c22:6n-3 | 1 |
205 | capillary/myocyte | 1 |
206 | cardio-chest | 1 |
207 | case/fatality | 1 |
208 | ccr4/ccr5 | 1 |
209 | cd3/b-cell | 1 |
210 | cd4+/8+ | 1 |
211 | cerebro-placental | 1 |
212 | charge-to-cost | 1 |
213 | chol/tg | 1 |
214 | cholesterol-phospholipid | 1 |
215 | cl/br | 1 |
216 | cold-/hot-start | 1 |
217 | collagen-ii/collagen-i | 1 |
218 | collagen/macrophage | 1 |
219 | compression-to-ventilation | 1 |
220 | content-validity | 1 |
221 | control-to-case | 1 |
222 | controller-to-reliever | 1 |
223 | coq10h2/coq10 | 1 |
224 | cost-benefice | 1 |
225 | cost-to-benefits | 1 |
226 | crae/crve | 1 |
227 | cream-to-oral | 1 |
228 | ctfα/β | 1 |
229 | curvature-radius | 1 |
230 | d3-labeling | 1 |
231 | dda/dspc | 1 |
232 | dexmedetomidine/midazolam | 1 |
233 | diameter/circumference | 1 |
234 | diastolic-pressure | 1 |
235 | drug-to-metabolite | 1 |
236 | earlylatrial | 1 |
237 | ecf/icf | 1 |
238 | efficacy-to-safety | 1 |
239 | efficacy-to-side-effect | 1 |
240 | emp/cells | 1 |
241 | emps/epcs | 1 |
242 | endismic | 1 |
243 | endo-epi | 1 |
244 | enrollment-to-surgery | 1 |
245 | enterobacteria/bifidobacteria | 1 |
246 | estimated-to-supplied | 1 |
247 | estrogen/testosterone | 1 |
248 | evlwi/itbvi | 1 |
249 | exercise-to-rest | 1 |
250 | exp/ins | 1 |
251 | fabp-aβ42 | 1 |
252 | fc/l | 1 |
253 | fe/ni | 1 |
254 | feed-egg | 1 |
255 | fp2/fp1 | 1 |
256 | ft4/ft3 | 1 |
257 | gain/feed | 1 |
258 | gc/at | 1 |
259 | glutamate-creatine | 1 |
260 | glutathione/gssg | 1 |
261 | glx/cre | 1 |
262 | glycine/serine | 1 |
263 | hamstring-to-quadriceps | 1 |
264 | hdl/tg | 1 |
265 | hdl2-c/hdl3-c | 1 |
266 | hdlc/cholesterol | 1 |
267 | heart/weigh | 1 |
268 | hexanal/3-methylbutanal | 1 |
269 | horwitz | 1 |
270 | hr2/hr1 | 1 |
271 | hydroxybupropion/bupropion | 1 |
272 | iaat/scat | 1 |
273 | ifnγ/il-6 | 1 |
274 | igf-i/bp3 | 1 |
275 | igf/igfbp-3 | 1 |
276 | igfbp-2/igfbp-3 | 1 |
277 | igfbp-3/igf-i | 1 |
278 | igfbp2/igfbp3 | 1 |
279 | igg1/igg2a | 1 |
280 | igg2/igg1 | 1 |
281 | il-10/tnf-α | 1 |
282 | il-18/il-18bp | 1 |
283 | il-1ra-to-il-1 | 1 |
284 | il-8/il-8* | 1 |
285 | il-8/protein | 1 |
286 | infarct-to-risk | 1 |
287 | insulin-to-cho | 1 |
288 | insulin-to-proinsulin | 1 |
289 | ipi/c-peptide | 1 |
290 | ipsilateral-to-contralateral | 1 |
291 | ir/100 | 1 |
292 | kidney-to-body | 1 |
293 | kv1.3/kv1.5 | 1 |
294 | lactitol/mannitol | 1 |
295 | lactulose/l-rhamnose | 1 |
296 | lc3-ii/lc3i | 1 |
297 | ldl-c-hdl-c | 1 |
298 | ldl-c/ldl-apob | 1 |
299 | ldl-c/tg | 1 |
300 | ldl/ldl-cholesterol | 1 |
301 | lecithin/sphingomyelin | 1 |
302 | left-atrium-to-aorta | 1 |
303 | lf-to-hf | 1 |
304 | lfmsna-to-hfmsna | 1 |
305 | lick/face | 1 |
306 | lignin/phenol | 1 |
307 | lipid-to-peptide | 1 |
308 | liver-to-heart | 1 |
309 | liver-to-lesion-contrast | 1 |
310 | liver-to-mediastinum | 1 |
311 | liver-to-plasma | 1 |
312 | low-spectral-energy | 1 |
313 | lpl/hl | 1 |
314 | lumen-to-wall | 1 |
315 | lvedv/lvedp | 1 |
316 | lvess/esvi | 1 |
317 | m/c-peptide | 1 |
318 | m3/m2 | 1 |
319 | m=3.10 | 1 |
320 | mda/tas | 1 |
321 | member-to-provider | 1 |
322 | met/cysta | 1 |
323 | metal/carbon | 1 |
324 | methylcytosine/cytosine | 1 |
325 | mf/es | 1 |
326 | mi-stroke | 1 |
327 | mid-waist/hip | 1 |
328 | milk-to-serum | 1 |
329 | mo/w | 1 |
330 | mobility/fvc | 1 |
331 | mpv-to-liver | 1 |
332 | mufa/pufa | 1 |
333 | muscle/fiber | 1 |
334 | myocardium-to-liver | 1 |
335 | nbd/mab | 1 |
336 | nflx/flx | 1 |
337 | ngf/prongf | 1 |
338 | nipam/am | 1 |
339 | noise-to-signal | 1 |
340 | nordothiepin/dothiepin | 1 |
341 | nox/creatinine | 1 |
342 | ntx/bap | 1 |
343 | nuclear-to-cytoplasm | 1 |
344 | observed/theoretic | 1 |
345 | oestradiol/testosterone | 1 |
346 | oh/c | 1 |
347 | oi/pi | 1 |
348 | on-current/off-current | 1 |
349 | ova-igg4/egg-ige | 1 |
350 | oxide/hydride | 1 |
351 | p-ampk/tampk | 1 |
352 | p-mypt/mypt | 1 |
353 | p-vegfr-2/vegfr-2 | 1 |
354 | pa/aorta | 1 |
355 | parasite-reduction | 1 |
356 | pc/lysopc | 1 |
357 | pces/nces | 1 |
358 | peak/height | 1 |
359 | pf4/anticoagulant | 1 |
360 | pgi2/txa2 | 1 |
361 | phenanthrene/anthracene | 1 |
362 | phosphocreatine/adenosine-triphosphate | 1 |
363 | phosphocreatine/βatp | 1 |
364 | phospholamban-serca2 | 1 |
365 | phosphomonoesters/phosphodiesters | 1 |
366 | pic/tat | 1 |
367 | pku/hpa | 1 |
368 | pl/pm | 1 |
369 | placenta/blood | 1 |
370 | plasma/tissue | 1 |
371 | pon/apoa-i | 1 |
372 | powder-liquid | 1 |
373 | ppi/pi | 1 |
374 | prevalence-rate | 1 |
375 | product/substrate | 1 |
376 | proinsulin-to-insulin | 1 |
377 | prostacyclin/thromboxane | 1 |
378 | proteinuria-to-creatinine | 1 |
379 | protoplast-to-sporoplast | 1 |
380 | ptv/gtv | 1 |
381 | pufa+mufa-to-/sfa | 1 |
382 | pufa+mufa-to-sfa | 1 |
383 | pufa-to-sfa | 1 |
384 | pufa/mufa | 1 |
385 | qt/q2 | 1 |
386 | qt/sq2 | 1 |
387 | rantes/protein | 1 |
388 | reach-path | 1 |
389 | reflection-to-question | 1 |
390 | risk-to-reward | 1 |
391 | risk/cost/benefit | 1 |
392 | risk/hazard | 1 |
393 | rmma/microarousal | 1 |
394 | roughness-area | 1 |
395 | rrcbf | 1 |
396 | rrcbv | 1 |
397 | rvp/sap | 1 |
398 | s/oh | 1 |
399 | sal-t/c | 1 |
400 | scattering-absorption | 1 |
401 | scd163/stweak | 1 |
402 | sema4d/plexin-b1 | 1 |
403 | serum-cholesterol/hdl-cholesterol | 1 |
404 | serum/mic | 1 |
405 | sfa/ufa | 1 |
406 | sft/rft | 1 |
407 | silica-to-alumina | 1 |
408 | smoker/non-smoker | 1 |
409 | smr/theta | 1 |
410 | solid/solution | 1 |
411 | spf/pf-uva | 1 |
412 | str-e/a | 1 |
413 | striatum-to-reference | 1 |
414 | sub-molar | 1 |
415 | subject-averaged | 1 |
416 | sucrose-to-rfo | 1 |
417 | surface/core | 1 |
418 | sv/lvedp | 1 |
419 | syrup-to-tablet | 1 |
420 | systolic-pressure | 1 |
421 | t-helper/suppressor | 1 |
422 | t.chol/hdl-c | 1 |
423 | tcd4+/tcd8+ | 1 |
424 | tcpo2/fio2 | 1 |
425 | testosterone-to-cortisol | 1 |
426 | testosterone/dihydrotestosterone | 1 |
427 | tg/leptin | 1 |
428 | tgfα/tgfβ1 | 1 |
429 | tnfr1/tnfr2 | 1 |
430 | troughto-peak | 1 |
431 | tumor-to-inflammation | 1 |
432 | tumor-to-plasma | 1 |
433 | tumor/plasma | 1 |
434 | tumour-to-blood | 1 |
435 | tv-e/a | 1 |
436 | type-token | 1 |
437 | ucoc/coc | 1 |
438 | vat-to-sat | 1 |
439 | vfas/alkalinity | 1 |
440 | vh-to-cd | 1 |
441 | vldl-c/lh | 1 |
442 | vldl-cholesterol/plasma-triglyceride | 1 |
443 | vldl-cholesterol/triglyceride | 1 |
444 | vldl-triglyceride/vldl-cholesterol | 1 |
445 | volume/surface | 1 |
446 | vt/ic | 1 |
447 | waist-to-thigh | 1 |
448 | wet-to-dry-weight | 1 |
449 | width/length | 1 |
450 | work/recovery | 1 |
451 | yolk-to-albumen | 1 |
452 | zhsf1a/zhsf1b | 1 |
453 | zpl/france | 1 |
454 | α-/β-mhc | 1 |
455 | β-hcg/plgf | 1 |
456 | μ-calpain/calpastatin | 1 |
457 | ω3/ω6 | 1 |
1 | 'hazard | 1 |
2 | 'hdl-cholesterol | 2 |
3 | 'odds | 4 |
4 | 'p/n | 1 |
5 | 'wall-to-lumen | 1 |
6 | 'win | 1 |
7 | +dp/dtmax-edv | 2 |
8 | +p/p | 1 |
9 | 1-ohp/3-ohbap | 1 |
10 | 17hsd1/17hsd2 | 1 |
11 | 18:2/18:1 | 1 |
12 | 2/16α-oh | 1 |
13 | 20:3/18:2 | 2 |
14 | 20:4n-6/20:5n-3 | 1 |
15 | 2:16 | 4 |
16 | 2:16α-hydroxyestrone | 1 |
17 | 30:15 | 24 |
18 | 30∶15 | 1 |
19 | 4-/6-sulfated | 1 |
20 | 4:2:1 | 1 |
21 | 4r/3r | 1 |
22 | 5-hiaa/5-ht | 3 |
23 | 5-methylfurfural/2-acetylfuran | 1 |
24 | 5α/5β-the | 1 |
25 | 6-h/0-h | 1 |
26 | 8:1:9 | 1 |
27 | 8:2:2 | 1 |
28 | 9:7:7 | 1 |
29 | a260-280 | 1 |
30 | a260/280 | 1 |
31 | above-the-knee/elbow-the-knee | 1 |
32 | abstract-to-publication | 2 |
33 | acth/e | 1 |
34 | activator/adhesive | 2 |
35 | adiponectin-leptin | 5 |
36 | adiponectin/fabp4 | 1 |
37 | ag-to-uag | 1 |
38 | ag/tg | 1 |
39 | albuminuria-to-creatinine | 1 |
40 | alc/amc | 23 |
41 | aldosterone-renin | 2 |
42 | aldosterone-to-creatinine | 1 |
43 | aldosterone/bnp | 2 |
44 | am/em | 1 |
45 | amylose/amylopectin | 1 |
46 | anaerobe-to-aerobe | 1 |
47 | analyte/creatinine | 1 |
48 | ang-1/ang-2 | 9 |
49 | ang-2/ang-1 | 2 |
50 | anti-xa/iia | 1 |
51 | apo-b/apo-a-1 | 1 |
52 | apo-b/apo-a1 | 2 |
53 | apo-b/apo-ai | 3 |
54 | apo-b100/apo-a1 | 1 |
55 | apoa-1/apob | 3 |
56 | apoa-i/apoc-iii | 1 |
57 | apob-100/b-48 | 1 |
58 | apob/apoa-i | 33 |
59 | apob100/apoa1 | 2 |
60 | apoc-iii/apoc-ii | 1 |
61 | apoj/pon | 5 |
62 | area-to-mass | 4 |
63 | arginine-to-dimethylarginine | 7 |
64 | asleep/awake | 4 |
65 | asp/bsp | 3 |
66 | b/se | 1 |
67 | bacillus/coccus | 4 |
68 | background-to-signal | 1 |
69 | bacteroidetes-to-firmicutes | 1 |
70 | balloon/annulus | 1 |
71 | bax/bcl-2expression | 1 |
72 | bax\bcl-2 | 1 |
73 | benefit/harms | 2 |
74 | benefits-risk | 1 |
75 | beta/alpha-lipoprotein | 1 |
76 | blackburne-peel | 1 |
77 | body-surface-to-mass | 1 |
78 | brm/mp | 1 |
79 | bromide/chlorine | 1 |
80 | c-ldl/c-hdl | 1 |
81 | c-peptide/creatinine | 2 |
82 | c16/c18 | 3 |
83 | c16:1n-7/c16:0 | 1 |
84 | c18:2/c18:3 | 1 |
85 | c20:5n-3/c22:6n-3 | 1 |
86 | campesterol-to-cholesterol | 3 |
87 | campesterol-to-lathosterol | 9 |
88 | capillary-to-fiber | 3 |
89 | capillary/myocyte | 1 |
90 | carbohydrate-to-insulin | 3 |
91 | carbohydrate-to-protein | 3 |
92 | carbohydrate/protein-equivalent | 2 |
93 | cardio-chest | 1 |
94 | case/fatality | 1 |
95 | ccr4/ccr5 | 1 |
96 | cd3/b-cell | 1 |
97 | cd4+/8+ | 1 |
98 | ceramide/cholesterol | 2 |
99 | cerebral-umbilical | 7 |
100 | cerebro-placental | 1 |
101 | charge-to-cost | 1 |
102 | chlorophyll/carotenoid | 2 |
103 | chol/hdl | 3 |
104 | chol/tg | 1 |
105 | cholestanol-to-cholesterol | 4 |
106 | cholesterol-phospholipid | 1 |
107 | cholesterol-phospholipids | 2 |
108 | cholesterol/lecithin | 2 |
109 | cholesterol/triglyceride | 5 |
110 | choline-to-creatine | 2 |
111 | cl/br | 1 |
112 | col2/20 | 4 |
113 | cold-/hot-start | 1 |
114 | collagen-ii/collagen-i | 1 |
115 | collagen/macrophage | 1 |
116 | compression-to-ventilation | 1 |
117 | content-validity | 1 |
118 | control-to-case | 1 |
119 | controller-to-reliever | 1 |
120 | coq10h2/coq10 | 1 |
121 | cortisol/dhea-s | 3 |
122 | cost-benefice | 1 |
123 | cost-charge | 3 |
124 | cost-to-benefits | 1 |
125 | cost-to-charge | 11 |
126 | crae/crve | 1 |
127 | cream-to-oral | 1 |
128 | crystalloid/colloid | 7 |
129 | csf/serum | 7 |
130 | ctfα/β | 1 |
131 | curvature-radius | 1 |
132 | d3-labeling | 1 |
133 | dda/dspc | 1 |
134 | desmosterol/cholesterol | 3 |
135 | dexmedetomidine/midazolam | 1 |
136 | diameter/circumference | 1 |
137 | diastolic-pressure | 1 |
138 | drisk | 2 |
139 | drug-to-metabolite | 1 |
140 | drug/beeswax | 2 |
141 | earlylatrial | 1 |
142 | ecf/icf | 1 |
143 | ecp/albumin | 3 |
144 | ecp/eo | 6 |
145 | edv/mass | 2 |
146 | efficacy-to-safety | 1 |
147 | efficacy-to-side-effect | 1 |
148 | emp/cells | 1 |
149 | emps/epcs | 1 |
150 | endismic | 1 |
151 | endo-epi | 1 |
152 | enrollment-to-surgery | 1 |
153 | enterobacteria/bifidobacteria | 1 |
154 | enterobacteriaceae/bacteroidaceae | 3 |
155 | enzyme-to-substrate | 2 |
156 | estimated-to-supplied | 1 |
157 | estrogen/testosterone | 1 |
158 | evlwi/itbvi | 1 |
159 | evol/avol | 2 |
160 | exercise-to-rest | 1 |
161 | exp/ins | 1 |
162 | fabp-aβ42 | 1 |
163 | fc/l | 1 |
164 | fe/ni | 1 |
165 | feed-egg | 1 |
166 | feed-to-gain | 8 |
167 | firmicutes/bacteroidetes | 3 |
168 | fp2/fp1 | 1 |
169 | ft4/ft3 | 1 |
170 | g/r | 5 |
171 | gain/feed | 1 |
172 | gc/at | 1 |
173 | glutamate-creatine | 1 |
174 | glutathione/gssg | 1 |
175 | glx/cre | 1 |
176 | glycine/serine | 1 |
177 | gmeans | 6 |
178 | gsh-to-gssg | 2 |
179 | hamstring-to-quadriceps | 1 |
180 | hamstrings-to-quadriceps | 4 |
181 | hdl/tg | 1 |
182 | hdl2-c/hdl3-c | 1 |
183 | hdlc/cholesterol | 1 |
184 | heart-mediastinum | 2 |
185 | heart-to-lung | 2 |
186 | heart/weigh | 1 |
187 | heterophil-to-lymphocyte | 2 |
188 | heterophil/lymphocyte | 8 |
189 | hexanal/3-methylbutanal | 1 |
190 | hmax/mmax | 7 |
191 | hop-1 | 2 |
192 | horwitz | 1 |
193 | hr2/hr1 | 1 |
194 | hva/da | 2 |
195 | hydroxybupropion/bupropion | 1 |
196 | iaat/scat | 1 |
197 | icpmax-to-map | 2 |
198 | icsv/dicsv | 4 |
199 | ifn-γ/il-10 | 3 |
200 | ifnγ/il-6 | 1 |
201 | igf-i/bp3 | 1 |
202 | igf/igfbp-3 | 1 |
203 | igfbp-2/igfbp-3 | 1 |
204 | igfbp-3/igf-i | 1 |
205 | igfbp2/igfbp3 | 1 |
206 | igg1/igg2a | 1 |
207 | igg2/igg1 | 1 |
208 | igg2a/igg1 | 2 |
209 | ihad/ihab | 2 |
210 | il-10/tnf-α | 1 |
211 | il-18/il-10 | 2 |
212 | il-18/il-18bp | 1 |
213 | il-1ra-to-il-1 | 1 |
214 | il-4/interferon-gamma | 2 |
215 | il-6-to-il-10 | 3 |
216 | il-8/il-8* | 1 |
217 | il-8/protein | 1 |
218 | infarct-to-risk | 1 |
219 | inhabitation | 3 |
220 | insulin-to-carbohydrate | 3 |
221 | insulin-to-cho | 1 |
222 | insulin-to-glucagon | 2 |
223 | insulin-to-proinsulin | 1 |
224 | iodine-to-creatinine | 6 |
225 | ipi/c-peptide | 1 |
226 | ipsilateral-to-contralateral | 1 |
227 | ir/100 | 1 |
228 | kidney-to-body | 1 |
229 | kv1.3/kv1.5 | 1 |
230 | l-arginine/adma | 2 |
231 | lacman | 8 |
232 | lactitol/mannitol | 1 |
233 | lactulose/l-rhamnose | 1 |
234 | lc3-ii/lc3i | 1 |
235 | ldl-c-hdl-c | 1 |
236 | ldl-c/ldl-apob | 1 |
237 | ldl-c/tg | 1 |
238 | ldl/ldl-c | 4 |
239 | ldl/ldl-cholesterol | 1 |
240 | lecithin/sphingomyelin | 1 |
241 | left-atrium-to-aorta | 1 |
242 | lf-to-hf | 1 |
243 | lfmsna-to-hfmsna | 1 |
244 | lick/face | 1 |
245 | lignin/phenol | 1 |
246 | lipid-to-peptide | 1 |
247 | liver-to-heart | 1 |
248 | liver-to-lesion-contrast | 1 |
249 | liver-to-mediastinum | 1 |
250 | liver-to-plasma | 1 |
251 | liver-to-spleen | 8 |
252 | losartan/e-3174 | 2 |
253 | low-spectral-energy | 1 |
254 | lpl/hl | 1 |
255 | lumen-to-wall | 1 |
256 | lung/myocardium | 2 |
257 | lvedv/lvedp | 1 |
258 | lvess/esvi | 1 |
259 | m/c-peptide | 1 |
260 | m3/m2 | 1 |
261 | m=3.10 | 1 |
262 | mda/sod | 2 |
263 | mda/tas | 1 |
264 | media-to-lumen | 2 |
265 | member-to-provider | 1 |
266 | met/cysta | 1 |
267 | metal/carbon | 1 |
268 | methylcytosine/cytosine | 1 |
269 | mf/es | 1 |
270 | mg-to-a1c | 2 |
271 | mi-stroke | 1 |
272 | mid-waist/hip | 1 |
273 | milk-to-serum | 1 |
274 | mo/w | 1 |
275 | mobility/fvc | 1 |
276 | mpv-to-liver | 1 |
277 | mpv-to-spleen | 2 |
278 | mtdna/gdna | 10 |
279 | mufa/pufa | 1 |
280 | muscle-thickness | 2 |
281 | muscle/fiber | 1 |
282 | myocardium-to-liver | 1 |
283 | myosin/actin | 6 |
284 | n2ba/n2b | 2 |
285 | naa-to-choline | 2 |
286 | naa-to-creatine | 2 |
287 | nbd/mab | 1 |
288 | neopterin-to-creatinine | 2 |
289 | neutrophil-lymphocyte | 10 |
290 | nflx/flx | 1 |
291 | ngf/prongf | 1 |
292 | nicotine/cotinine | 7 |
293 | nipam/am | 1 |
294 | noise-to-signal | 1 |
295 | nordothiepin/dothiepin | 1 |
296 | nox/creatinine | 1 |
297 | ntx/bap | 1 |
298 | nuclear-to-cytoplasm | 1 |
299 | nucleus-to-cytoplasm | 3 |
300 | nucleus/cytoplasm | 2 |
301 | observed/theoretic | 1 |
302 | odds | 17,857 |
303 | oestradiol/testosterone | 1 |
304 | oh/c | 1 |
305 | oi/pi | 1 |
306 | on-current/off-current | 1 |
307 | ova-igg4/egg-ige | 1 |
308 | oxide/hydride | 1 |
309 | p-ampk/tampk | 1 |
310 | p-mypt/mypt | 1 |
311 | p-vegfr-2/vegfr-2 | 1 |
312 | pa/aorta | 1 |
313 | pa/oa | 3 |
314 | pai-1/pai-2 | 3 |
315 | parasite-reduction | 1 |
316 | pc/lysopc | 1 |
317 | pce/nce | 5 |
318 | pces/nces | 1 |
319 | peak/height | 1 |
320 | pem/pwt | 2 |
321 | peto-odds | 6 |
322 | pf4/anticoagulant | 1 |
323 | pgi2/txa2 | 1 |
324 | phenanthrene/anthracene | 1 |
325 | phosphocreatine/adenosine-triphosphate | 1 |
326 | phosphocreatine/βatp | 1 |
327 | phospholamban-serca2 | 1 |
328 | phosphomonoesters/phosphodiesters | 1 |
329 | pic/tat | 1 |
330 | picp/ictp | 3 |
331 | pku/hpa | 1 |
332 | pl/pm | 1 |
333 | placenta/blood | 1 |
334 | plasma/tissue | 1 |
335 | pon/apoa-i | 1 |
336 | population-to-neurosurgeon | 3 |
337 | powder-liquid | 1 |
338 | ppi/pi | 1 |
339 | precursor-to-product | 3 |
340 | prevalence-rate | 1 |
341 | preventer-to-reliever | 3 |
342 | product/substrate | 1 |
343 | proinsulin-to-insulin | 1 |
344 | prostacyclin/thromboxane | 1 |
345 | protamine-to-heparin | 2 |
346 | proteinuria-to-creatinine | 1 |
347 | protoplast-to-sporoplast | 1 |
348 | ptv/gtv | 1 |
349 | pufa+mufa-to-/sfa | 1 |
350 | pufa+mufa-to-sfa | 1 |
351 | pufa-to-sfa | 1 |
352 | pufa/mufa | 1 |
353 | qt/q2 | 1 |
354 | qt/sq2 | 1 |
355 | qtc/qtt | 3 |
356 | r-tfa/sfa | 2 |
357 | r/o | 2 |
358 | rantes/il-8 | 2 |
359 | rantes/protein | 1 |
360 | rc/abd | 3 |
361 | reach-path | 1 |
362 | redfield | 2 |
363 | reflection-to-question | 1 |
364 | risk-to-reward | 1 |
365 | risk/cost/benefit | 1 |
366 | risk/hazard | 1 |
367 | rmma/microarousal | 1 |
368 | root/shoot | 2 |
369 | roughness-area | 1 |
370 | rrcbf | 1 |
371 | rrcbv | 1 |
372 | rvp/sap | 1 |
373 | s/oh | 1 |
374 | sal-t/c | 1 |
375 | sam/sah | 6 |
376 | scattering-absorption | 1 |
377 | scd163/stweak | 1 |
378 | sdfv | 8 |
379 | sema4d/plexin-b1 | 1 |
380 | serum-cholesterol/hdl-cholesterol | 1 |
381 | serum/mic | 1 |
382 | sfa/ufa | 1 |
383 | sflt1/plgf | 7 |
384 | sft/rft | 1 |
385 | silica-to-alumina | 1 |
386 | smoker/non-smoker | 1 |
387 | smr/theta | 1 |
388 | solid/solution | 1 |
389 | spf/pf-uva | 1 |
390 | sphingomyelin/lecithin | 2 |
391 | st/s | 5 |
392 | stj/aa | 5 |
393 | str-e/a | 1 |
394 | striatum-to-reference | 1 |
395 | sub-molar | 1 |
396 | subject-averaged | 1 |
397 | subscapular/triceps | 3 |
398 | sucrose-to-rfo | 1 |
399 | sun/creatinine | 2 |
400 | surface-area-to-mass | 2 |
401 | surface/core | 1 |
402 | surfactant/oil | 2 |
403 | sv/lvedp | 1 |
404 | swt/twt | 2 |
405 | syrup-to-tablet | 1 |
406 | systolic-pressure | 1 |
407 | t-helper/suppressor | 1 |
408 | t.chol/hdl-c | 1 |
409 | tag/hdl-c | 2 |
410 | tcd4+/tcd8+ | 1 |
411 | tcpo2/fio2 | 1 |
412 | testosterone-to-cortisol | 1 |
413 | testosterone/dihydrotestosterone | 1 |
414 | testosterone/estradiol | 6 |
415 | tg/cholesterol | 3 |
416 | tg/leptin | 1 |
417 | tgfα/tgfβ1 | 1 |
418 | timp-1/mmp-3 | 2 |
419 | tnfr1/tnfr2 | 1 |
420 | torsion-to-shortening | 2 |
421 | total-c/hdl-c | 4 |
422 | trough-to-peak | 16 |
423 | troughto-peak | 1 |
424 | tumor-to-inflammation | 1 |
425 | tumor-to-plasma | 1 |
426 | tumor/plasma | 1 |
427 | tumour-to-blood | 1 |
428 | tv-e/a | 1 |
429 | type-token | 1 |
430 | ucoc/coc | 1 |
431 | uv/ma | 4 |
432 | val/lys | 6 |
433 | valid-invalid | 3 |
434 | vat-to-sat | 1 |
435 | vat/sat | 8 |
436 | vat/tat | 5 |
437 | vfas/alkalinity | 1 |
438 | vh-to-cd | 1 |
439 | vldl-c/lh | 1 |
440 | vldl-cholesterol/plasma-triglyceride | 1 |
441 | vldl-cholesterol/triglyceride | 1 |
442 | vldl-triglyceride/vldl-cholesterol | 1 |
443 | volume/surface | 1 |
444 | vt/ic | 1 |
445 | waist-thigh | 2 |
446 | waist-to-thigh | 1 |
447 | wet-to-dry-weight | 1 |
448 | width/length | 1 |
449 | work/recovery | 1 |
450 | yolk-to-albumen | 1 |
451 | zhsf1a/zhsf1b | 1 |
452 | zpl/france | 1 |
453 | α-/β-mhc | 1 |
454 | β-hcg/plgf | 1 |
455 | δdhpg/δne | 2 |
456 | μ-calpain/calpastatin | 1 |
457 | ω3/ω6 | 1 |
1 | il-8/il-8* | 1 |
2 | cd4+/8+ | 1 |
3 | tcd4+/tcd8+ | 1 |
4 | ir/100 | 1 |
5 | il-6-to-il-10 | 3 |
6 | il-18/il-10 | 2 |
7 | ifn-γ/il-10 | 3 |
8 | m=3.10 | 1 |
9 | coq10h2/coq10 | 1 |
10 | col2/20 | 4 |
11 | a260-280 | 1 |
12 | a260/280 | 1 |
13 | c16:1n-7/c16:0 | 1 |
14 | apo-b/apo-a-1 | 1 |
15 | ang-2/ang-1 | 2 |
16 | il-1ra-to-il-1 | 1 |
17 | hop-1 | 2 |
18 | 4:2:1 | 1 |
19 | 18:2/18:1 | 1 |
20 | apo-b100/apo-a1 | 1 |
21 | apo-b/apo-a1 | 2 |
22 | apob100/apoa1 | 2 |
23 | sema4d/plexin-b1 | 1 |
24 | igg2/igg1 | 1 |
25 | igg2a/igg1 | 2 |
26 | fp2/fp1 | 1 |
27 | hr2/hr1 | 1 |
28 | tgfα/tgfβ1 | 1 |
29 | ang-1/ang-2 | 9 |
30 | pai-1/pai-2 | 3 |
31 | bax\bcl-2 | 1 |
32 | p-vegfr-2/vegfr-2 | 1 |
33 | fabp-aβ42 | 1 |
34 | 8:2:2 | 1 |
35 | 20:3/18:2 | 2 |
36 | phospholamban-serca2 | 1 |
37 | pgi2/txa2 | 1 |
38 | 17hsd1/17hsd2 | 1 |
39 | m3/m2 | 1 |
40 | tcpo2/fio2 | 1 |
41 | qt/q2 | 1 |
42 | qt/sq2 | 1 |
43 | tnfr1/tnfr2 | 1 |
44 | 20:4n-6/20:5n-3 | 1 |
45 | c20:5n-3/c22:6n-3 | 1 |
46 | igfbp-2/igfbp-3 | 1 |
47 | igf/igfbp-3 | 1 |
48 | timp-1/mmp-3 | 2 |
49 | c18:2/c18:3 | 1 |
50 | igf-i/bp3 | 1 |
51 | igfbp2/igfbp3 | 1 |
52 | ft4/ft3 | 1 |
53 | losartan/e-3174 | 2 |
54 | adiponectin/fabp4 | 1 |
55 | kv1.3/kv1.5 | 1 |
56 | 30:15 | 24 |
57 | 30∶15 | 1 |
58 | ccr4/ccr5 | 1 |
59 | ifnγ/il-6 | 1 |
60 | 2:16 | 4 |
61 | ω3/ω6 | 1 |
62 | 9:7:7 | 1 |
63 | rantes/il-8 | 2 |
64 | c16/c18 | 3 |
65 | apob-100/b-48 | 1 |
66 | 8:1:9 | 1 |
67 | str-e/a | 1 |
68 | tv-e/a | 1 |
69 | igg1/igg2a | 1 |
70 | stj/aa | 5 |
71 | hva/da | 2 |
72 | roughness-area | 1 |
73 | pufa+mufa-to-sfa | 1 |
74 | pufa-to-sfa | 1 |
75 | pufa+mufa-to-/sfa | 1 |
76 | r-tfa/sfa | 2 |
77 | sfa/ufa | 1 |
78 | pufa/mufa | 1 |
79 | mufa/pufa | 1 |
80 | anti-xa/iia | 1 |
81 | enterobacteria/bifidobacteria | 1 |
82 | uv/ma | 4 |
83 | l-arginine/adma | 2 |
84 | il-4/interferon-gamma | 2 |
85 | liver-to-plasma | 1 |
86 | tumor-to-plasma | 1 |
87 | tumor/plasma | 1 |
88 | mtdna/gdna | 10 |
89 | silica-to-alumina | 1 |
90 | lfmsna-to-hfmsna | 1 |
91 | pa/oa | 3 |
92 | pku/hpa | 1 |
93 | smr/theta | 1 |
94 | left-atrium-to-aorta | 1 |
95 | pa/aorta | 1 |
96 | met/cysta | 1 |
97 | spf/pf-uva | 1 |
98 | zhsf1a/zhsf1b | 1 |
99 | n2ba/n2b | 2 |
100 | ihad/ihab | 2 |
101 | nbd/mab | 1 |
102 | ldl-c/ldl-apob | 1 |
103 | apoa-1/apob | 3 |
104 | hdl2-c/hdl3-c | 1 |
105 | ldl-c-hdl-c | 1 |
106 | total-c/hdl-c | 4 |
107 | tag/hdl-c | 2 |
108 | t.chol/hdl-c | 1 |
109 | ldl/ldl-c | 4 |
110 | oh/c | 1 |
111 | sal-t/c | 1 |
112 | mg-to-a1c | 2 |
113 | α-/β-mhc | 1 |
114 | vt/ic | 1 |
115 | serum/mic | 1 |
116 | endismic | 1 |
117 | observed/theoretic | 1 |
118 | alc/amc | 23 |
119 | ucoc/coc | 1 |
120 | pc/lysopc | 1 |
121 | dda/dspc | 1 |
122 | mobility/fvc | 1 |
123 | rc/abd | 3 |
124 | vh-to-cd | 1 |
125 | gain/feed | 1 |
126 | subject-averaged | 1 |
127 | estimated-to-supplied | 1 |
128 | 4-/6-sulfated | 1 |
129 | valid-invalid | 3 |
130 | crystalloid/colloid | 7 |
131 | chlorophyll/carotenoid | 2 |
132 | cholesterol-phospholipid | 1 |
133 | powder-liquid | 1 |
134 | redfield | 2 |
135 | tumour-to-blood | 1 |
136 | placenta/blood | 1 |
137 | mda/sod | 2 |
138 | risk-to-reward | 1 |
139 | 'hazard | 1 |
140 | risk/hazard | 1 |
141 | acth/e | 1 |
142 | enterobacteriaceae/bacteroidaceae | 3 |
143 | anaerobe-to-aerobe | 1 |
144 | lick/face | 1 |
145 | volume/surface | 1 |
146 | cost-benefice | 1 |
147 | pce/nce | 5 |
148 | zpl/france | 1 |
149 | striatum-to-reference | 1 |
150 | diameter/circumference | 1 |
151 | oxide/hydride | 1 |
152 | vldl-cholesterol/plasma-triglyceride | 1 |
153 | cholesterol/triglyceride | 5 |
154 | vldl-cholesterol/triglyceride | 1 |
155 | ipi/c-peptide | 1 |
156 | m/c-peptide | 1 |
157 | lipid-to-peptide | 1 |
158 | above-the-knee/elbow-the-knee | 1 |
159 | collagen/macrophage | 1 |
160 | ova-igg4/egg-ige | 1 |
161 | cost-to-charge | 11 |
162 | cost-charge | 3 |
163 | 5α/5β-the | 1 |
164 | asleep/awake | 4 |
165 | mi-stroke | 1 |
166 | prostacyclin/thromboxane | 1 |
167 | phenanthrene/anthracene | 1 |
168 | naa-to-choline | 2 |
169 | arginine-to-dimethylarginine | 7 |
170 | proteinuria-to-creatinine | 1 |
171 | albuminuria-to-creatinine | 1 |
172 | iodine-to-creatinine | 6 |
173 | aldosterone-to-creatinine | 1 |
174 | neopterin-to-creatinine | 2 |
175 | c-peptide/creatinine | 2 |
176 | analyte/creatinine | 1 |
177 | sun/creatinine | 2 |
178 | nox/creatinine | 1 |
179 | nicotine/cotinine | 7 |
180 | glycine/serine | 1 |
181 | bromide/chlorine | 1 |
182 | methylcytosine/cytosine | 1 |
183 | glutamate-creatine | 1 |
184 | naa-to-creatine | 2 |
185 | choline-to-creatine | 2 |
186 | oestradiol/testosterone | 1 |
187 | estrogen/testosterone | 1 |
188 | testosterone/dihydrotestosterone | 1 |
189 | 2:16α-hydroxyestrone | 1 |
190 | δdhpg/δne | 2 |
191 | glx/cre | 1 |
192 | surface/core | 1 |
193 | diastolic-pressure | 1 |
194 | systolic-pressure | 1 |
195 | b/se | 1 |
196 | control-to-case | 1 |
197 | lactulose/l-rhamnose | 1 |
198 | phosphocreatine/adenosine-triphosphate | 1 |
199 | prevalence-rate | 1 |
200 | insulin-to-carbohydrate | 3 |
201 | enzyme-to-substrate | 2 |
202 | product/substrate | 1 |
203 | drug-to-metabolite | 1 |
204 | neutrophil-lymphocyte | 10 |
205 | heterophil-to-lymphocyte | 2 |
206 | heterophil/lymphocyte | 8 |
207 | capillary/myocyte | 1 |
208 | plasma/tissue | 1 |
209 | activator/adhesive | 2 |
210 | crae/crve | 1 |
211 | rrcbf | 1 |
212 | ecf/icf | 1 |
213 | sflt1/plgf | 7 |
214 | β-hcg/plgf | 1 |
215 | ngf/prongf | 1 |
216 | lf-to-hf | 1 |
217 | ag-to-uag | 1 |
218 | feed-egg | 1 |
219 | d3-labeling | 1 |
220 | torsion-to-shortening | 2 |
221 | heart-to-lung | 2 |
222 | gsh-to-gssg | 2 |
223 | glutathione/gssg | 1 |
224 | ldl-c/tg | 1 |
225 | ag/tg | 1 |
226 | hdl/tg | 1 |
227 | chol/tg | 1 |
228 | 6-h/0-h | 1 |
229 | sam/sah | 6 |
230 | heart/weigh | 1 |
231 | waist-to-thigh | 1 |
232 | waist-thigh | 2 |
233 | vldl-c/lh | 1 |
234 | 2/16α-oh | 1 |
235 | s/oh | 1 |
236 | reach-path | 1 |
237 | width/length | 1 |
238 | apob/apoa-i | 33 |
239 | pon/apoa-i | 1 |
240 | igfbp-3/igf-i | 1 |
241 | collagen-ii/collagen-i | 1 |
242 | lc3-ii/lc3i | 1 |
243 | apo-b/apo-ai | 3 |
244 | apoc-iii/apoc-ii | 1 |
245 | apoa-i/apoc-iii | 1 |
246 | fe/ni | 1 |
247 | oi/pi | 1 |
248 | ppi/pi | 1 |
249 | endo-epi | 1 |
250 | evlwi/itbvi | 1 |
251 | lvess/esvi | 1 |
252 | trough-to-peak | 16 |
253 | troughto-peak | 1 |
254 | scd163/stweak | 1 |
255 | p-ampk/tampk | 1 |
256 | infarct-to-risk | 1 |
257 | benefits-risk | 1 |
258 | drisk | 2 |
259 | fc/l | 1 |
260 | cerebral-umbilical | 7 |
261 | earlylatrial | 1 |
262 | hexanal/3-methylbutanal | 1 |
263 | background-to-signal | 1 |
264 | noise-to-signal | 1 |
265 | ipsilateral-to-contralateral | 1 |
266 | cream-to-oral | 1 |
267 | rmma/microarousal | 1 |
268 | cerebro-placental | 1 |
269 | c-ldl/c-hdl | 1 |
270 | chol/hdl | 3 |
271 | blackburne-peel | 1 |
272 | lpl/hl | 1 |
273 | surfactant/oil | 2 |
274 | lumen-to-wall | 1 |
275 | cd3/b-cell | 1 |
276 | testosterone/estradiol | 6 |
277 | lignin/phenol | 1 |
278 | 'hdl-cholesterol | 2 |
279 | serum-cholesterol/hdl-cholesterol | 1 |
280 | ldl/ldl-cholesterol | 1 |
281 | vldl-triglyceride/vldl-cholesterol | 1 |
282 | cholestanol-to-cholesterol | 4 |
283 | campesterol-to-cholesterol | 3 |
284 | hdlc/cholesterol | 1 |
285 | ceramide/cholesterol | 2 |
286 | tg/cholesterol | 3 |
287 | desmosterol/cholesterol | 3 |
288 | campesterol-to-lathosterol | 9 |
289 | testosterone-to-cortisol | 1 |
290 | lactitol/mannitol | 1 |
291 | evol/avol | 2 |
292 | nipam/am | 1 |
293 | dexmedetomidine/midazolam | 1 |
294 | am/em | 1 |
295 | pl/pm | 1 |
296 | nuclear-to-cytoplasm | 1 |
297 | nucleus-to-cytoplasm | 3 |
298 | nucleus/cytoplasm | 2 |
299 | lung/myocardium | 2 |
300 | liver-to-mediastinum | 1 |
301 | heart-mediastinum | 2 |
302 | milk-to-serum | 1 |
303 | csf/serum | 7 |
304 | 'p/n | 1 |
305 | lacman | 8 |
306 | 5-methylfurfural/2-acetylfuran | 1 |
307 | liver-to-spleen | 8 |
308 | mpv-to-spleen | 2 |
309 | type-token | 1 |
310 | yolk-to-albumen | 1 |
311 | media-to-lumen | 2 |
312 | 'wall-to-lumen | 1 |
313 | feed-to-gain | 8 |
314 | carbohydrate-to-protein | 3 |
315 | il-8/protein | 1 |
316 | rantes/protein | 1 |
317 | beta/alpha-lipoprotein | 1 |
318 | cholesterol/lecithin | 2 |
319 | sphingomyelin/lecithin | 2 |
320 | lecithin/sphingomyelin | 1 |
321 | carbohydrate-to-insulin | 3 |
322 | proinsulin-to-insulin | 1 |
323 | insulin-to-proinsulin | 1 |
324 | ecp/albumin | 3 |
325 | aldosterone-renin | 2 |
326 | nordothiepin/dothiepin | 1 |
327 | protamine-to-heparin | 2 |
328 | μ-calpain/calpastatin | 1 |
329 | myosin/actin | 6 |
330 | amylose/amylopectin | 1 |
331 | adiponectin-leptin | 5 |
332 | tg/leptin | 1 |
333 | 'win | 1 |
334 | metal/carbon | 1 |
335 | population-to-neurosurgeon | 3 |
336 | insulin-to-glucagon | 2 |
337 | hydroxybupropion/bupropion | 1 |
338 | bax/bcl-2expression | 1 |
339 | abstract-to-publication | 2 |
340 | compression-to-ventilation | 1 |
341 | tumor-to-inflammation | 1 |
342 | inhabitation | 3 |
343 | parasite-reduction | 1 |
344 | scattering-absorption | 1 |
345 | reflection-to-question | 1 |
346 | solid/solution | 1 |
347 | apoj/pon | 5 |
348 | r/o | 2 |
349 | ecp/eo | 6 |
350 | sucrose-to-rfo | 1 |
351 | insulin-to-cho | 1 |
352 | +p/p | 1 |
353 | ntx/bap | 1 |
354 | 1-ohp/3-ohbap | 1 |
355 | icpmax-to-map | 2 |
356 | rvp/sap | 1 |
357 | il-18/il-18bp | 1 |
358 | lvedv/lvedp | 1 |
359 | sv/lvedp | 1 |
360 | mid-waist/hip | 1 |
361 | brm/mp | 1 |
362 | aldosterone/bnp | 2 |
363 | asp/bsp | 3 |
364 | phosphocreatine/βatp | 1 |
365 | picp/ictp | 3 |
366 | g/r | 5 |
367 | 4r/3r | 1 |
368 | sub-molar | 1 |
369 | cl/br | 1 |
370 | capillary-to-fiber | 3 |
371 | muscle/fiber | 1 |
372 | member-to-provider | 1 |
373 | smoker/non-smoker | 1 |
374 | controller-to-reliever | 1 |
375 | preventer-to-reliever | 3 |
376 | myocardium-to-liver | 1 |
377 | mpv-to-liver | 1 |
378 | t-helper/suppressor | 1 |
379 | cortisol/dhea-s | 3 |
380 | st/s | 5 |
381 | mda/tas | 1 |
382 | emps/epcs | 1 |
383 | odds | 17,857 |
384 | 'odds | 4 |
385 | peto-odds | 6 |
386 | cholesterol-phospholipids | 2 |
387 | mf/es | 1 |
388 | pces/nces | 1 |
389 | firmicutes/bacteroidetes | 3 |
390 | bacteroidetes-to-firmicutes | 1 |
391 | emp/cells | 1 |
392 | benefit/harms | 2 |
393 | gmeans | 6 |
394 | exp/ins | 1 |
395 | hamstring-to-quadriceps | 1 |
396 | hamstrings-to-quadriceps | 4 |
397 | subscapular/triceps | 3 |
398 | phosphomonoesters/phosphodiesters | 1 |
399 | area-to-mass | 4 |
400 | surface-area-to-mass | 2 |
401 | body-surface-to-mass | 1 |
402 | edv/mass | 2 |
403 | muscle-thickness | 2 |
404 | cost-to-benefits | 1 |
405 | bacillus/coccus | 4 |
406 | curvature-radius | 1 |
407 | balloon/annulus | 1 |
408 | val/lys | 6 |
409 | gc/at | 1 |
410 | iaat/scat | 1 |
411 | vat-to-sat | 1 |
412 | vat/sat | 8 |
413 | pic/tat | 1 |
414 | vat/tat | 5 |
415 | efficacy-to-side-effect | 1 |
416 | precursor-to-product | 3 |
417 | syrup-to-tablet | 1 |
418 | sft/rft | 1 |
419 | 5-hiaa/5-ht | 3 |
420 | peak/height | 1 |
421 | wet-to-dry-weight | 1 |
422 | risk/cost/benefit | 1 |
423 | pf4/anticoagulant | 1 |
424 | carbohydrate/protein-equivalent | 2 |
425 | on-current/off-current | 1 |
426 | root/shoot | 2 |
427 | p-mypt/mypt | 1 |
428 | liver-to-heart | 1 |
429 | cold-/hot-start | 1 |
430 | protoplast-to-sporoplast | 1 |
431 | liver-to-lesion-contrast | 1 |
432 | cardio-chest | 1 |
433 | exercise-to-rest | 1 |
434 | charge-to-cost | 1 |
435 | qtc/qtt | 3 |
436 | pem/pwt | 2 |
437 | swt/twt | 2 |
438 | rrcbv | 1 |
439 | +dp/dtmax-edv | 2 |
440 | sdfv | 8 |
441 | icsv/dicsv | 4 |
442 | ptv/gtv | 1 |
443 | mo/w | 1 |
444 | hmax/mmax | 7 |
445 | drug/beeswax | 2 |
446 | nflx/flx | 1 |
447 | kidney-to-body | 1 |
448 | low-spectral-energy | 1 |
449 | enrollment-to-surgery | 1 |
450 | work/recovery | 1 |
451 | efficacy-to-safety | 1 |
452 | content-validity | 1 |
453 | case/fatality | 1 |
454 | vfas/alkalinity | 1 |
455 | horwitz | 1 |
456 | il-10/tnf-α | 1 |
457 | ctfα/β | 1 |